Vivos Therapeutics, Inc. (VVOS)
Nasdaq: VVOS · Surgical & Medical Instruments & Apparatus · Littleton, CO · filing with the SEC since 2017
Who runs Vivos Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Huntsman Ronald Kirk
Chief Executive Officer. First filing Dec 2020, latest Sep 18, 2026, 10 filings in all.
Officers reporting now
2
of 7 people with a filing in the last fifteen months
Directors reporting now
5
9 people on the record since 2020
Officerssales are open-market, Oct 27, 2025 to Oct 27, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Huntsman Ronald Kirk | Chief Executive Officer | Dec 2020 | Sep 18, 2026 | none |
| Amman Bradford K. | Principal Accounting Officer | Dec 2020 | Aug 26, 2026 | none |
Directorssales are open-market, Oct 27, 2025 to Oct 27, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Krammer Anja B | director | Dec 2020 | Oct 27, 2026 | none |
| Green Ralph Elias | director | Dec 2020 | Oct 26, 2026 | none |
| Lindsay Mark F. | director | Dec 2020 | Oct 26, 2026 | none |
| Johnson Gregg C | director | Feb 2026 | Sep 18, 2026 | none |
| Sokolow Leonard J | director | Dec 2020 | Sep 18, 2026 | none |
Owners of more than 10% of a classsales are open-market, Oct 27, 2025 to Oct 27, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Skaff Michael C | 10% owner | Jun 2025 | Jul 15, 2026 | none |
| V-Co Investors 4 LLC | 10% owner | Jul 2026 | Jul 15, 2026 | none |
| V-Co Investors 3 LLC | 10% owner | Mar 2026 | Apr 10, 2026 | none |
Earlier names on the record2, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.